Spironolactone in the Treatment of Acne Vulgaris in Females

Background: There has been an increasing incidence in the prevalence of adult acne vulgaris ranging between 30-50%. Androgens play a significant role in the pathogenesis of acne. Recently, hormonal therapy has been advocated as a first line therapy for acne vulgaris among female patients who experience premenstrual flares, acne beginning or worsening in adulthood and […]

Tags: acne vulgaris, adult female, low dose, randomized controlled trial, spironolactone
Posted in Conference Notes |